Kishore Alugupalli

Alugupalli is a professor and scientific researcher with over 25 years of experience in immunology, microbiology, infectious diseases, and hematology. He is a faculty member in the Department of Microbiology & Immunology at Thomas Jefferson University (TJU). He is also a member of the Kimmel Cancer Center, an NCI-designated cancer research center at TJU. He is co-founder, chairman of the SAB, and Chief Scientific Officer of SRIN Therapeutics Inc.